Study number 780581
Dates
Apr 09 2026-May 07 2026
Location
Madison, Wisconsin
Age
24-60
Gender
Male and Female
Smoker
No
Compensation
$13,759
Group
C1
This is a research study for an investigational drug being developed for the treatment of patients with heart failure with preserved ejection fraction, chronic kidney disease in type 2 diabetes mellitus, and atherosclerotic cardiovascular disease.
Madison, WI is currently recruiting Healthy Men and Women, age 24-60.
Refer a friend & receive $350 per qualified referral
Women Eligibility Criteria
Body Mass Index
Smoking criteria
Screening procedures
C1
Check-in: Apr 9th
Check-out: May 5th
Follow-up visit: May 7th